Bulletin from extraordinary general meeting of Arcam AB (publ) December 6, 2013
Fri , December 6, 2013 11:18 ET
The Extraordinary General Meeting of Arcam AB 6 December 2013 were as follows:
Decision to split ( "split " ) and amendment of articles of association
The AGM approved the Board's proposal to resolve the split of shares and decide if connected amendment of the Articles.
a) Split of shares
A split of shares 4:1 , meaning that 1 (one) share is divided into 4 (four ) shares.
Further information on the procedure for the split will be published in conjunction with the Board of Directors decides on the record date.
b) Amendment of the Articles of Association
In view of the above split of shares , the meeting decided that § 5 ( Number of shares) in the current articles of association be amended to the following wording
The number of shares shall be not less than 12,000,000 and not more than 48 000 , 000.
Resolution authorizing the Board
The meeting resolved to authorize the Board , until the next Annual General Meeting, on one or more occasions, to issue new shares, issue of convertible bonds or warrants. Issue shall be transacted with or without deviation from the shareholders' preferential rights and with or without non-cash , settlement or other conditions . The overall increase of the share capital pursuant to the authorization shall not exceed 1 600 000, representing an increase of share capital from the current 16 741 633,50 to a maximum of 18 341 633.50 , ie an increase by a maximum of just under 10%. The shares will be issued at the current market price .
This authorization is to give the Board flexibility in efforts to finance and facilitate accelerated expansion and development of the Company, its market and products.
Mölndal December 6, 2013
Arcam AB (publ)
Board of Directors
Arcam manufactures equipment to directly from digital three-dimensional models produce components from metal powder , known as Additive Manufacturing. Arcam technology, EBM ® , allows for cost-effective production of products with advanced functionality. Arcam's market is global with customers primarily in orthopedic implants and aerospace industries . The company was founded in 1997 and is listed on NASDAQ OMX. The head office and production facilities are located in Mölndal. Service offices located in USA , UK, Italy and China.
